|
1
|
Jinturkar KA, Anish C, Kumar MK, Bagchi T,
Panda AK and Misra AR: Liposomal formulations of etoposide and
docetaxel for p53 mediated enhanced cytotoxicity in lung cancer
cell lines. Biomaterials. 33:2492–2507. 2012. View Article : Google Scholar
|
|
2
|
Sengupta S, Tyagi P, Velpandian T, et al:
Etoposide encapsulated in positively charged liposomes:
pharmacokinetic studies in mice and formulation stability studies.
Pharmacol Res. 42:459–464. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maeda H: Macromolecular therapeutics in
cancer treatment: the EPR effect and beyond. J Control Release.
164:138–144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tang J, Zhang L, Liu Y, et al: Synergistic
targeted delivery of payload into tumor cells by dual-ligand
liposomes co-modified with cholesterol anchored transferrin and
TAT. Int J Pharm. 454:31–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shmeeda H, Amitay Y, Gorin J, et al:
Delivery of zoledronic acid encapsulated in folate-targeted
liposome results in potent in vitro cytotoxic activity on tumor
cells. J Control Release. 146:76–83. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Q, Tang J, Fu L, et al: A
pH-responsive α-helical cell penetrating peptide-mediated liposomal
delivery system. Biomaterials. 34:7980–7993. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang X, Xin H, Gu J, et al: Solid tumor
penetration by integrin-mediated pegylated poly(trimethylene
carbonate) nanoparticles loaded with paclitaxel. Biomaterials.
34:1739–1746. 2013. View Article : Google Scholar
|
|
8
|
Han L, Huang R, Liu S, et al:
Peptide-conjugated PAMAM for targeted doxorubicin delivery to
transferrin receptor overexpressed tumors. Mol Pharm. 7:2156–2165.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mei D, Gao H, Gong W, et al: Anti glioma
effect of doxorubicin loaded liposomes modified with angiopep-2.
Afr J Pharm Pharmacol. 5:409–414. 2011. View Article : Google Scholar
|
|
10
|
Gao H, Qian J, Yang Z, et al: Whole-cell
SELEX aptamer-functionalised
poly(ethyleneglycol)-poly(ɛ-caprolactone) nanoparticles for
enhanced targeted glioblastoma therapy. Biomaterials. 33:6264–6272.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang L, Chan JM, Gu FX, et al:
Self-assembled lipid - polymer hybrid nanoparticles: a robust drug
delivery platform. ACS Nano. 2:1696–1702. 2008. View Article : Google Scholar
|
|
12
|
Owen SC, Patel N, Logie J, et al:
Targeting HER2+ breast cancer cells: lysosomal
accumulation of anti-HER2 antibodies is influenced by antibody
binding site and conjugation to polymeric nanoparticles. J Control
Release. 172:395–404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rossiello R, Carriero MV and Giordano GG:
Distribution of ferritin, transferrin and lactoferrin in breast
carcinoma tissue. J Clin Pathol. 37:51–55. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shindelman JE, Ortmeyer AE and Sussman HH:
Demonstration of the transferrin receptor in human breast cancer
tissue. Potential marker for identifying dividing cells. Int J
Cancer. 27:329–334. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han L, Li J, Huang S, et al:
Peptide-conjugated polyamidoamine dendrimer as a nanoscale
tumor-targeted T1 magnetic resonance imaging contrast agent.
Biomaterials. 32:2989–2998. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee JH, Engler JA, Collawn JF and Moore
BA: Receptor mediated uptake of peptides that bind the human
transferrin receptor. Eur J Biochem. 268:2004–2012. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oh S, Kim BJ, Singh NP, et al: Synthesis
and anti-cancer activity of covalent conjugates of artemisinin and
a transferrin-receptor targeting peptide. Cancer Lett. 274:33–39.
2009. View Article : Google Scholar
|
|
18
|
Sharma G, Modgil A, Sun C, Singh J, et al:
Grafting of cell-penetrating peptide to receptor-targeted liposomes
improves their transfection efficiency and transport across
blood-brain barrier model. J Pharm Sci. 101:2468–2478. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kibria G, Hatakeyama H, Ohga N, et al:
Dual-ligand modification of PEGylated liposomes shows better cell
selectivity and efficient gene delivery. J Control Release.
153:141–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qin Y, Chen H, Zhang Q, et al: Liposome
formulated with TAT-modified cholesterol for improving brain
delivery and therapeutic efficacy on brain glioma in animals. Int J
Pharm. 420:304–312. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gupta B, Levchenko TS and Torchilin VP:
Intracellular delivery of large molecules and small particles by
cell-penetrating proteins and peptides. Adv Drug Deliv Rev.
57:637–651. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Banks WA, Robinson SM, Nath A, et al:
Permeability of the blood-brain barrier to HIV-1 Tat. Exp Neurol.
193:218–227. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brooks H, Lebleu B and Vivès E: Tat
peptide-mediated cellular delivery: back to basics. Adv Drug Deliv
Rev. 57:559–577. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Torchilin VP, Rammohan R, Weissig V and
Levchenko TS: TAT peptide on the surface of liposomes affords their
efficient intracellular delivery even at low temperature and in the
presence of metabolic inhibitors. Proc Nat Acad Sci USA.
98:8786–8791. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Allen TM, Brandeis E, Hansen CB, et al: A
new strategy for attachment of antibodies to sterically stabilized
liposomes resulting in efficient targeting to cancer cells. Biochim
Biophys Acta. 1237:99–108. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Du S, Pan H, Lu W, et al: Cyclic
Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of
hepatic fibrosis in rats. J Pharmacol Exp Ther. 322:560–568. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li F, Sun J, Wang J, et al: Effect of
hepatocyte growth factor encapsulated in targeted liposomes on
liver cirrhosis. J Control Release. 131:77–82. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao LY, Liu XY, Chen CJ, et al: Core-shell
type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA
delivery. Biomaterials. 35:2066–2078. 2014. View Article : Google Scholar
|
|
29
|
McNeeley KM, Karathanasis E, Annapragada
AV and Bellamkonda RV: Masking and triggered unmasking of targeting
ligands on nanocarriers to improve drug delivery to brain tumors.
Biomaterials. 30:3986–3995. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kuai R, Yuan W, Qin Y, et al: Efficient
delivery of payload into tumor cells in a controlled manner by TAT
and thiolytic cleavable PEG co-modified liposomes. Mol Pharm.
7:1816–1826. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jiang T, Zhang Z, Zhang Y, et al:
Dual-functional liposomes based on pH-responsive cell-penetrating
peptide and hyaluronic acid for tumor-targeted anticancer drug
delivery. Biomaterials. 33:9246–9258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maeda N, Takeuchi Y, Takada M, et al:
Anti-neovascular therapy by use of tumor neovasculature-targeted
long-circulating liposome. J Control Release. 100:41–52. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang T, Choi MK, Cui FD, Kim JS, et al:
Preparation and evaluation of paclitaxel-loaded PEGylated
immunoliposome. J Control Release. 120:169–177. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu Y, Li K, Pan J, et al: Folic acid
conjugated nanoparticles of mixed lipid monolayer shell and
biodegradable polymer core for targeted delivery of Docetaxel.
Biomaterials. 31:330–338. 2010. View Article : Google Scholar
|
|
35
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fukumura D, Xu L, Chen Y, Gohongi T, Seed
B and Jain RK: Hypoxia and acidosis independently up-regulate
vascular endothelial growth factor transcription in brain tumors in
vivo. Cancer Res. 61:6020–6024. 2001.PubMed/NCBI
|
|
37
|
Jain RK: Delivery of molecular and
cellular medicine to solid tumors. Adv Drug Deliv Rev. 46:149–168.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kobayashi H, Man S, Graham CH, et al:
Acquired multicellular-mediated resistance to alkylating agents in
cancer. Proc Natl Acad Sci USA. 90:3294–3298. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Du J, Lu WL, Ying X, et al: Dual-targeting
topotecan liposomes modified with tamoxifen and wheat germ
agglutinin significantly improve drug transport across the
blood-brain barrier and survival of brain tumor-bearing animals.
Mol Pharm. 6:905–917. 2009. View Article : Google Scholar : PubMed/NCBI
|
